NIH-funded research R01 grant

Using ultrasound to enhance treatment for chronic wounds

Official title: A theranostic ultrasound approach to improve chronic wound treatment using phase-change contrast agents

Funded at Univ of North Carolina Chapel Hill · NIH-10913590 · Data updated 2026-11-12

This study is exploring a new way to help heal stubborn wounds by using ultrasound and special agents that can boost the delivery of antibiotics right where they're needed, making it easier for patients with chronic wounds to fight off infections and heal better.

More Ultrasound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startAugust 24, 2023
Project endJuly 31, 2027
Funding year2024
Award (this year)$538,033
NIH project number5R01AI167978-02
Project IDNIH-10913590 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from chronic wounds, particularly those with infections related to diabetes or other comorbidities.

Less likely to help

Patients with acute wounds or those not affected by chronic infections may not benefit from this research.

What this research studies

This research investigates a novel approach to improve the treatment of chronic wounds by utilizing ultrasound technology combined with phase-change contrast agents. These agents can enhance the delivery of antibiotics directly to infected areas, particularly targeting biofilms that hinder healing. The study aims to address the significant challenge of bacterial infections in chronic wounds, which often lead to severe complications such as amputations. By improving antibiotic efficacy, the research seeks to provide a more effective treatment option for patients suffering from chronic wounds.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for chronic wounds, reducing the risk of complications such as infections and amputations.

How similar studies have gone: Other research has shown promise in using ultrasound technology for drug delivery, indicating potential success for this novel approach.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Papadopoulou, Virginie — Univ of North Carolina Chapel Hill
  • Study coordinator: Papadopoulou, Virginie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.